- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07709039
"Comparison of of Volume-Controlled Ventilation and Pressure-Controlled Ventilation Modes in Laparoscopic Cholecystectomy" (VCV VS PCV)
"Comparison of the Effects of Volume-Controlled Ventilation and Pressure-Controlled Ventilation Modes on Compliance and End-Tidal CO2 In Patients Undergoing Laparoscopic Cholecystectomy"
This randomized controlled trial compares volume-controlled ventilation and pressure-controlled ventilation in adult patients undergoing elective laparoscopic cholecystectomy under general anesthesia. The study evaluates the effects of both ventilation modes on static lung compliance and end-tidal carbon dioxide at predefined intraoperative time points. The objective is to determine whether pressure-controlled ventilation provides improved respiratory mechanics and more effective ventilation compared with volume-controlled ventilation during laparoscopic surgery.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Laparoscopic cholecystectomy is commonly performed under general anesthesia with carbon dioxide pneumoperitoneum. Increased intra-abdominal pressure during pneumoperitoneum can alter respiratory mechanics, reduce lung compliance, and increase airway pressures. These physiological changes may affect ventilation and gas exchange during laparoscopic procedures.
This randomized controlled trial is designed to compare two commonly used mechanical ventilation strategies: volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV). Participants are randomly allocated in a 1:1 ratio to receive either ventilation mode during elective laparoscopic cholecystectomy. A standardized general anesthetic technique and consistent intraoperative ventilation targets are maintained in both groups to minimize variations in perioperative management.
In the VCV group, ventilation is delivered using a preset tidal volume, whereas in the PCV group, inspiratory pressure is adjusted to achieve the target tidal volume. The ventilation protocol includes a tidal volume of 8 mL/kg, an initial respiratory rate of 12 breaths per minute with subsequent adjustment according to end-tidal carbon dioxide levels, an inspiratory-to-expiratory ratio of 1:2, a positive end-expiratory pressure (PEEP) of 5 cmH₂O, and an inspired oxygen concentration (FiO₂) of 40%.
Intraoperative respiratory parameters, including static lung compliance and end-tidal carbon dioxide (EtCO₂), are assessed at predefined stages of the procedure: five minutes after induction of anesthesia, fifteen minutes after carbon dioxide insufflation in the Trendelenburg position, and ten minutes after carbon dioxide desufflation. Measurements are obtained using the integrated monitoring system of the anesthesia workstation.
The study aims to evaluate the physiological effects of the two ventilation strategies during laparoscopic surgery and determine whether either approach offers advantages in maintaining respiratory mechanics and adequate ventilation. The findings may contribute to evidence-based selection of mechanical ventilation strategies for patients undergoing elective laparoscopic cholecystectomy.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Punjab Province
-
Multan, Punjab Province, Pakistan, 00000
- Nishtar Medical University and Hospital, Multan
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adult patients aged 25-50 years.
- Either sex.
- ASA physical status I or II.
- Scheduled for elective laparoscopic cholecystectomy under general anaesthesia.
- Written informed consent obtained.
Exclusion Criteria:
- ASA physical status III or IV.
- Body mass index (BMI) greater than 35 kg/m².
- Significant pulmonary disease (e.g., COPD, asthma, restrictive lung disease).
- Significant cardiovascular disease.
- Pregnancy.
- Previous upper abdominal surgery.
- Conversion to open cholecystectomy.
- Refusal to participate.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Volume Controlled Ventilation
Participants receive volume-controlled ventilation during elective laparoscopic cholecystectomy under general anesthesia. |
Mechanical ventilation delivered using the volume-controlled ventilation mode during elective laparoscopic cholecystectomy under general anesthesia. Ventilation is provided with a tidal volume of 8 mL/kg, respiratory rate adjusted to maintain end-tidal carbon dioxide between 32 and 38 mmHg, PEEP of 5 cmH₂O, FiO₂ of 0.40, and an inspiratory-to-expiratory ratio of 1:2 throughout the surgical procedure. |
|
Eksperimentell: Pressure Controlled Ventilation
Participants receive pressure-controlled ventilation during elective laparoscopic cholecystectomy under general anesthesia. |
Mechanical ventilation delivered using the pressure-controlled ventilation mode during elective laparoscopic cholecystectomy under general anesthesia. Inspiratory pressure is adjusted to achieve a tidal volume of 8 mL/kg while maintaining end-tidal carbon dioxide between 32 and 38 mmHg, with PEEP of 5 cmH₂O, FiO₂ of 0.40, and an inspiratory-to-expiratory ratio of 1:2 throughout the surgical procedure. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Static Lung Compliance
Tidsramme: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Comparison of static lung compliance between the volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV) groups during elective laparoscopic cholecystectomy under general anesthesia. |
Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
|
End-Tidal Carbon Dioxide (EtCO₂)
Tidsramme: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Comparison of end-tidal carbon dioxide (EtCO₂) levels between the VCV and PCV groups. |
Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Peak Inspiratory Pressure
Tidsramme: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Comparison of peak inspiratory pressure between the VCV and PCV groups during laparoscopic cholecystectomy. |
Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 18717 / NMU
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Individual participant data will not be shared because no formal data-sharing plan has been established. Participant confidentiality and institutional ethical requirements will be maintained.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .